1 year return (CAGR)
166.58%
Virax Biolabs Group Limited Ordinary Shares Exchange (NASDAQ, USD)
VRAX
1.21
-0.11 (-6.05%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
-17.54%
5 year return (CAGR)
-
10 year return (CAGR)
-
Adobe 2026 Q3 – Is sentiment driving the price?
Read MoreMarketcap
1.39M
Price/Sales
100.37
Ent value
-4.06M
Price/Book
-
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 1.81 |
| Daily high | 1.86 |
| Daily low | 1.72 |
| Daily Volume | 40K |
| All-time high | 208.00 |
| 1y analyst estimate | 25.00 |
| Beta | 1.35 |
| EPS (TTM) | -13.77 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| VRAX | S&P500 | |
| Current price drop from All-time high | -99.42% | -3.00% |
| Highest price drop | -99.95% | -56.47% |
| Date of highest drop | 10 Apr 2026 | 9 Mar 2009 |
| Avg drop from high | -97.06% | -10.65% |
| Avg time to new high | 177 days | 12 days |
| Max time to new high | 1057 days | 1805 days |
News
